Therapeutic strategy for spontaneous rupture of primary hepatocellular carcinoma: report of 30 cases
-
摘要:
目的探讨肝细胞癌(HCC)自发破裂出血患者在治疗对策上的选择。方法对本院2008年1月-2011年12月收治的30例HCC破裂出血患者的临床资料进行回顾性分析,其中行Ⅰ期手术9例,急诊经导管肝动脉化疗栓塞术(TACE)治疗21例,TACE治疗后再手术切除10例,其余11例均为单纯TACE治疗,从临床治疗效果进行评价分析。计数资料比较采用卡方检验或Fisher’s检验。结果 21例经急诊TACE治疗者止血成功率为100%,其中10例患者TACE治疗后25周内进行Ⅱ期手术,术后病理证实均为HCC,术后3个月复查均未见腹腔肿瘤种植转移灶,术后1年存活率70%(7/10);9例行Ⅰ期手术切除的患者中,围手术期内死亡2例,3个月内发生腹腔或切口种植转移者5例(5/7),术后1年存活率44.4%(4/9);11例单纯TACE治疗患者术后1年存活率为27.3%(3/11)。急诊TACE联合手术切除HCC破裂出血在提高抢救成功率、减少术后并发症及提高患者生存时间上均优于急诊手术切除及单纯的TACE治疗。结论 HCC自发性破裂出血患者应首选急诊TACE治疗,再联合手术切除,可以明显...
Abstract:Objective To investigate the therapeutic strategy for spontaneous rupture of hepatocellular carcinoma ( HCC) . Methods A retrospective analysis was performed on the clinical data of 30 patients with HCC rupture hospitalized at our hospital from January 2008 to December2011, including nine patients treated by primary surgical tumor resection and 21 patients treated with emergency transcatheter arterial chemoembolization ( TACE) . Of the latter group, 10 patients underwent surgical tumor resection after TACE and the other 11 patients were treated with TACE alone. Treatment outcomes were evaluated and compared. Categorical data were compared using the chi- square test or Fisher's test. Results The success rate of hemostasis was 100% in the 21 patients treated with TACE, of whom 10 patients received tumor resection within 2- 5 weeks after TACE and HCC was confirmed by postoperative pathology. No peritoneal metastasis was noted three months after surgery. One- year survival rate was 70% ( 7 /10) . Of the nine patients treated by primary surgical tumor resection, two died during the perioperative period and five developed peritoneal or port- site metastasis within three months, and one- year survival rate was 44. 4% ( 4 /9) . For the 11 cases treated with TACE alone, one- year survival rate was 27. 3% ( 3 /11) . Conclusion TACE combined with surgical tumor resection is the preferred emergency treatment for spontaneous rupture of primary HCC. It can significantly increase the success rate of rescuing patients with HCC rupture and tumor resection rate, significantly decrease peritoneal metastasis rate, and prolong the survival of the patients.
-
[1]LYU XS, HE YM, LIU ZS, et al.Liver resection for spontaneous rupture of primary hepatocellular carcinoma[J].Chin J Hepatobiliary Surg, 2004, 10 (10) :668-669. (in Chinese) 吕新生, 何跃明, 刘志苏, 等.肝切除治疗原发性肝癌自发性破裂[J].中华肝胆外科杂志, 2004, 10 (10) :668-669. [2]LUO YX, LI C, WEN TF, et al.The choice of treatments for the spontaneous rupture of hepatocellular carcinoma[J].West China Med J, 2011, 26 (1) :85-86. (in Chinese) 罗永香, 李川, 文天夫, 等.原发性肝癌破裂出血的治疗选择[J].华西医学, 2011, 26 (1) :85-86. [3]CHEN XP, ZHANG WG.Further improving the treatment outcome in advanced hepatocellular carcinoma[J].J Clin Surg, 2008, 16 (9) :577-578. (in Chinese) 陈孝平, 张万广.进一步提高中晚期肝癌的治疗效果[J].临床外科杂志, 2008, 16 (9) :577-578. [4]WU PH, HUANG JH, LUO PF, et al.Interventional diagnosis and treatment in oncology[M].Beijing:Science Press, 2005:221-232. (in Chinese) 吴沛宏, 黄金华, 罗鹏飞, 等.肿瘤介入诊疗学[M].北京:科学出版社, 2005:221-232. [5]WANG YH, ZHANG Z, LE F, et al.Effect of chemotherapeutics and embolization on tumor inhibition and liver injury in TACE treatment of hepatic carcinoma[J].J Clin Hepatol, 2008, 24 (4) :272-274. (in Chinese) 王艳红, 张哲, 乐凡, 等.肝癌TACE中化疗和栓塞与肿瘤抑制和肝损伤关系的临床研究[J].临床肝胆病杂志, 2008, 24 (4) :272-274. [6] LI ZW, WANG YX, CAI L, et al.The treatment of TACE combined surgical resction for HCC rupture[J].Chin J Hepatobiliary Surg, 2012, 18 (10) :777-779. (in Chinese) 李志伟, 王元喜, 彩烈, 等.TACE联合手术切除治疗肝细胞肝癌破裂出血[J].中华肝胆外科杂志, 2012, 18 (10) :777-779. [7]ZOU QH, WU ZM, JIANG YS, et al.The clinical study of TACE combined with endogenetic field tumor hyperthermia system in treatment of primary hepatic carcinoma[J].J Clin Hepatol, 2008, 24 (4) :270-271. (in Chinese) 邹庆华, 武振明, 姜玉石, 等.肝动脉化疗栓塞联合内生场热疗治疗原发性肝癌的临床研究[J].临床肝胆病杂志, 2008, 24 (4) :270-271. [8]CHENG AL, KANG YK, CHEN Z, et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised double-blind, placebo-controlled trial[J].Lancet Oncol, 2009, 10 (1) :25-34. [9]XIN GJ, ZHUNAG SW, CAI YJ, et al.Clinical study of antiviral treatment combined with transcatheter arterial chemoemholization (TACE) in patients with hepatitis B cirrhosis complicated hepatocellular carcinoma[J].J Clin Hepatol, 2012, 28 (4) :267-269. (in Chinese) 辛桂杰, 庄树武, 蔡艳俊, 等.抗病毒联合经导管肝动脉化疗栓塞治疗乙型肝炎后肝硬化合并肝细胞癌患者的临床观察[J].临床肝胆病杂志, 2012, 28 (4) :267-269.
计量
- 文章访问数: 270
- HTML全文浏览量: 24
- PDF下载量: 44
- 被引次数: 0